Search Results - Jun‐Jie Yin
- Showing 1 - 19 results of 19
-
1
-
2
Pulse EPR Detection of Lipid Exchange between Protein-Rich Raft and Bulk Domains in the Membrane: Methodology Development and Its Application to Studies of Influenza Viral Membrane by Kazunori Kawasaki, Jun‐Jie Yin, Witold K. Subczynski, James S. Hyde, Akihiro Kusumi
Published 2001Artigo -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could i... by Suqin Zhu, Xiumei Jiang, Mary D. Boudreau, Guangxin Feng, Miao Yu, Shiyuan Dong, Haohao Wu, Mingyong Zeng, Jun‐Jie Yin
Published 2018Artigo -
11
-
12
WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer by Andrea Sand, Mitchel Piacsek, Deborah Donohoe, Aspen T. Duffin, Geoffrey T. Riddell, Chaoyang Sun, Ming‐Jer Tang, Richard Rovin, Judy A. Tjoe, Jun‐Jie Yin
Published 2019Artigo -
13
-
14
-
15
Hypoxic Culture Induces Expression of Sialin, a Sialic Acid Transporter, and Cancer-Associated Gangliosides Containing Non–Human Sialic Acid on Human Cancer Cells by Jun‐Jie Yin, Ayako Hashimoto, Mineko Izawa, Keiko Miyazaki, Guo-Yun Chen, Hiromu Takematsu, Yasunori Kozutsumi, Akemi Suzuki, Kimio Furuhata, Feng-Leng Cheng, Chun‐Hung Lin, Chihiro Sato, Ken Kitajima, Reiji Kannagi
Published 2006Artigo -
16
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm by Daniel J. McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, Qingxin Liu, Wei Mo, Hui Dai, Yiling Lu, Qinghua Yu, Zhenlin Ju, Jun‐Jie Yin, Christopher P. Vellano, Bryan T. Hennessy, Gordon B. Mills, Shiaw-Yih Lin
Published 2017Artigo -
17
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency by Chaoyang Sun, Jun‐Jie Yin, Yong Fang, Jian Chen, Kang Jin Jeong, Xiaohua Chen, Christopher P. Vellano, Zhenlin Ju, Wei Zhao, Dong Zhang, Yiling Lu, Funda Meric‐Bernstam, Timothy A. Yap, Maureen M. Hattersley, Mark J. O’Connor, Huawei Chen, Stephen E. Fawell, Shiaw‐Yih Lin, Guang Peng, Gordon B. Mills
Published 2018Artigo -
18
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers by Chaoyang Sun, Yong Fang, Jun‐Jie Yin, Jian Chen, Zhenlin Ju, Dong Zhang, Xiaohua Chen, Christopher P. Vellano, Kang Jin Jeong, Patrick Kwok‐Shing Ng, Agda Karina Eterovic, Neil E. Bhola, Yiling Lu, Shannon N. Westin, Jennifer R. Grandis, Shiaw‐Yih Lin, Kenneth L. Scott, Guang Peng, Joan S. Brugge, Gordon B. Mills
Published 2017Artigo -
19
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer by Daniel J. McGrail, Jeannine Garnett, Jun‐Jie Yin, Hui Dai, David Shih, Truong Lam, Yang Li, Chaoyang Sun, Yongsheng Li, Rosemarie Schmandt, Ji Yuan Wu, Limei Hu, Yulong Liang, Guang Peng, Eric Jonasch, David G. Menter, Melinda S. Yates, Scott Kopetz, Karen H. Lu, Russell R. Broaddus, Gordon B. Mills, Nidhi Sahni, Shiaw‐Yih Lin
Published 2020Artigo
Search Tools:
Related Subjects
Biology
Chemistry
Biochemistry
Cancer research
Gene
Genetics
Medicine
Cancer
Organic chemistry
Cancer cell
Cell biology
DNA
DNA damage
DNA repair
Mathematics
PARP inhibitor
Pharmacology
Poly ADP ribose polymerase
Polymerase
Internal medicine
Molecular biology
Oxygen
Physics
Synthetic lethality
Apoptosis
Bioinformatics
Cell culture
Chemotherapy
Combinatorics
Computational biology